Oriflame Cosmetics S.A. held its Annual General Meeting (AGM) and its
Extraordinary General Meeting (EGM) in Luxembourg today. The current directors
Magnus Brännström, Marie Ehrling, Lilian Fossum, Alexander af Jochnick, Jonas af
Jochnick, Robert af Jochnick, Helle Kruse Nielsen and Christian Salamon were
re-elected and Anders Dahlvig was elected to serve as members of the Board of
Directors of the Company until the next Annual General Meeting. Robert af
Jochnick was re-elected to serve as Chairman of the Board until the next Annual
General Meeting. KPMG Audit S.Ã . r.l. was re-elected auditor.
The AGM approved the Board of Director's resolution that a dividend of EUR 1.25
per share (or the Swedish Krona equivalent per Swedish Depository Receipt) shall
be paid in cash. Last day of trading in the Oriflame share including right to
receive dividend is 19 May 2010. Payment of the dividend is expected to occur
through Euroclear Sweden AB on 27 May 2010.
The shareholders of the Company approved all other resolutions that were
proposed at the AGM and EGM as set out in the convening notice.
[HUG#1417303]
Release in PDF:
http://hugin.info/134730/R/1417303/367740.pdf
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.